Frontlight ResearchEarly access
Peripheral artery disease trials in Poland
8 trials · From ClinicalTrials.gov, checked 14 November 2026. Ask the study team whether a trial fits you.
- Phase 3Not yet taking people in PolandReducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease
- Where
- Bydgoszcz, Chrzanów, Cracow, Gdansk, Lodz, Łódź, Oswiecim, Poznan, Warsaw
- Age
- 18 years and over
- People
- 7,050 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT07318610 · EU 2025-522954-37-00 - Phase 3Taking peopleEfficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
- Where
- Bydgoszcz, Elblag, Grudziądz, Komorniki, Leszno
- Age
- 18 years and over
- People
- 1,205 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07223593 · EU 2025-523283-21-00 - Phase 2/3Taking peopleCombined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Where
- Brodnica, Katowice, Łęczna, Lodz, Naklo N. Notecią, Pszczyna, Stalowa Wola, Szczecin, Tczew, Warsaw
- Age
- 18 years and over
- People
- 3,110 worldwide
- Run by
- CSL Behring
See details and how to joinNCT05485961 · EU 2022-500273-14-00 - No phaseTaking peopleVascular Complications in Patients Undergoing Peripheral Revascularization and Taking SGLT-2 Inhibitors
- Where
- Wroclaw
- Age
- 18 years and over
- People
- 300
- Run by
- Wroclaw Medical University
See details and how to joinNCT07157475 - No phaseTaking peoplePost-market Registry Study on the Safety and Efficacy of ZENFLEX Pro™ Peripheral Drug-eluting Stent System for Femoropopliteal Artery Lesions
- Where
- Chrzanów
- Age
- 18 years to 80 years
- People
- 153
- Run by
- MDCECRO LLC
See details and how to joinNCT07122167 - No phaseNot yet taking people in PolandPost-Market Study of ZENFLEX Pro Stent for Femoropopliteal Artery Lesions
- Where
- Chrzanów
- Age
- 18 years to 80 years
- People
- 153
- Run by
- Zhejiang Zylox Medical Device Co., Ltd.
See details and how to joinNCT07049120 - Phase 3Active, not recruitingThe Effect of Allopurinol on the Risk of Cardiovascular Events in Patients with Cardiovascular Risk
- Where
- Cracow, Gdansk, Jaksice, Katowice, Kielce, Lodz, Poznan, Słupsk, Warsaw, Wroclaw
- Age
- 40 years to 70 years
- People
- 1,116
- Run by
- Poznan University of Medical Sciences
See details and how to joinNCT05943821 · EU 2024-517610-15-00 - No phaseTaking peopleSTAR-PAK Study: Evaluating the Safety and Efficacy of PAK® (Paclitaxel Coated Balloon) in Treating Atherosclerotic Femoro-Popliteal Lesions
- Where
- Chrzanów, Szczecin
- Age
- 18 years and over
- People
- 120 worldwide
- Run by
- Balton Sp.zo.o.
See details and how to joinNCT06734221